Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 574

1.

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

Kavsak PA, Lam CSP, Saenger AK, Jaffe AS, Collinson P, Pulkki K, Omland T, Lefèvre G, Body R, Ordóñez-Llanos J, Apple FS.

Clin Chem. 2019 Aug 6. pii: clinchem.2019.306621. doi: 10.1373/clinchem.2019.306621. [Epub ahead of print]

PMID:
31387884
2.

Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock.

Vallabhajosyula S, Ya'Qoub L, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS, Gersh BJ, Kashani K.

ESC Heart Fail. 2019 Aug;6(4):874-877. doi: 10.1002/ehf2.12482. Epub 2019 Jul 4.

3.

Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population.

Jentzer JC, van Diepen S, Barsness GW, Katz JN, Wiley BM, Bennett CE, Mankad SV, Sinak LJ, Best PJ, Herrmann J, Jaffe AS, Murphy JG, Morrow DA, Wright RS, Bell MR, Anavekar NS.

Am Heart J. 2019 Sep;215:12-19. doi: 10.1016/j.ahj.2019.05.012. Epub 2019 Jun 4.

PMID:
31260901
4.

Should myocardial infarction type 2 be regarded as two separate entities?

Thygesen K, Jaffe AS.

Eur Heart J. 2019 Jun 26. pii: ehz451. doi: 10.1093/eurheartj/ehz451. [Epub ahead of print] No abstract available.

PMID:
31243435
5.

Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.

Asleh R, Enriquez-Sarano M, Jaffe AS, Manemann SM, Weston SA, Jiang R, Roger VL.

J Am Coll Cardiol. 2019 May 14;73(18):2286-2295. doi: 10.1016/j.jacc.2019.02.046.

PMID:
31072572
6.

Type 2 Myocardial Infarction: JACC Review Topic of the Week.

Sandoval Y, Jaffe AS.

J Am Coll Cardiol. 2019 Apr 16;73(14):1846-1860. doi: 10.1016/j.jacc.2019.02.018. Review.

PMID:
30975302
7.

Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock.

Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr, Barsness GW.

J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.

PMID:
30975295
8.

Cardiac magnetic resonance in patients with elevated troponin and normal coronary angiography.

Bhatia S, Anstine C, Jaffe AS, Gersh BJ, Chandrasekaran K, Foley TA, Hodge D, Anavekar NS.

Heart. 2019 Aug;105(16):1231-1236. doi: 10.1136/heartjnl-2018-314631. Epub 2019 Apr 4.

PMID:
30948519
9.

Temporal trends and outcomes of prolonged invasive mechanical ventilation and tracheostomy use in acute myocardial infarction with cardiogenic shock in the United States.

Vallabhajosyula S, Dunlay SM, Kashani K, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS, Barsness GW.

Int J Cardiol. 2019 Jun 15;285:6-10. doi: 10.1016/j.ijcard.2019.03.008. Epub 2019 Mar 6.

PMID:
30871802
10.

High-Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta-Analysis.

Samaha E, Avila A, Helwani MA, Ben Abdallah A, Jaffe AS, Scott MG, Nagele P.

J Am Heart Assoc. 2019 Mar 19;8(6):e008626. doi: 10.1161/JAHA.118.008626.

11.

Sample matrix and high-sensitivity cardiac troponin I assays.

Kavsak PA, Roy C, Malinowski P, Clark L, Lamers S, Bamford K, Hill S, Worster A, Jaffe AS.

Clin Chem Lab Med. 2019 Apr 24;57(5):745-751. doi: 10.1515/cclm-2018-1100.

PMID:
30838842
12.

Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?

Pereira NL, Desai VK, Jaffe AS.

Eur J Heart Fail. 2019 May;21(5):609-612. doi: 10.1002/ejhf.1451. Epub 2019 Mar 4. No abstract available.

PMID:
30834697
13.

Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.

Januzzi JL Jr, Mahler SA, Christenson RH, Rymer J, Newby LK, Body R, Morrow DA, Jaffe AS.

J Am Coll Cardiol. 2019 Mar 12;73(9):1059-1077. doi: 10.1016/j.jacc.2018.12.046. Epub 2019 Feb 21. Review.

PMID:
30798981
14.

Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure.

Chang IC, Dispenzieri A, Scott CG, Lin G, Jaffe AS, Klarich KW, Grogan M.

Mayo Clin Proc. 2019 Mar;94(3):447-454. doi: 10.1016/j.mayocp.2018.07.025. Epub 2019 Feb 2.

PMID:
30718069
16.

Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction.

Anand A, Shah ASV, Beshiri A, Jaffe AS, Mills NL.

Clin Chem. 2019 Mar;65(3):484-489. doi: 10.1373/clinchem.2018.298059. Epub 2019 Jan 9.

PMID:
30626631
17.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617. No abstract available. Erratum in: Circulation. 2018 Nov 13;138(20):e652.

PMID:
30571511
18.

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.

Muchtar E, Kumar SK, Gertz MA, Grogan M, AbouEzzeddine OF, Jaffe AS, Dispenzieri A.

Blood. 2019 Feb 14;133(7):763-766. doi: 10.1182/blood-2018-10-875252. Epub 2018 Dec 13. No abstract available.

PMID:
30545829
19.

High-Sensitivity Cardiac Troponin I Levels in Normal and Hypertensive Pregnancy.

Ravichandran J, Woon SY, Quek YS, Lim YC, Noor EM, Suresh K, Vigneswaran R, Vasile V, Shah A, Mills NL, Sickan J, Beshiri A, Jaffe AS.

Am J Med. 2019 Mar;132(3):362-366. doi: 10.1016/j.amjmed.2018.11.017. Epub 2018 Nov 30.

PMID:
30503877
20.

High-sensitivity cardiac troponin T increases after stress echocardiography.

Samaha E, Brown J, Brown F, Martinez SC, Scott M, Jaffe AS, Davila-Roman VG, Nagele P.

Clin Biochem. 2019 Jan;63:18-23. doi: 10.1016/j.clinbiochem.2018.11.013. Epub 2018 Nov 28.

PMID:
30502318
21.

Between-day versus within-day imprecision using the Abbott high-sensitivity cardiac troponin I assay at concentrations around 5 ng/l.

Kavsak PA, Millar E, McLay G, Clark L, Jaffe AS.

Clin Chim Acta. 2019 Feb;489:58-60. doi: 10.1016/j.cca.2018.11.031. Epub 2018 Nov 28. No abstract available.

PMID:
30502326
22.

Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation.

Fabbri A, Bachetti C, Ottani F, Morelli A, Benazzi B, Spiezia S, Cortigiani M, Dorizzi R, Jaffe AS, Galvani M.

Intern Emerg Med. 2019 Apr;14(3):403-410. doi: 10.1007/s11739-018-1996-6. Epub 2018 Nov 29.

PMID:
30499074
23.

Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting.

Sandoval Y, Sharain K, Saenger AK, Smith SW, Apple FS, Jaffe AS.

Minerva Med. 2019 Apr;110(2):139-156. doi: 10.23736/S0026-4806.18.05874-3. Epub 2018 Nov 27. Review.

PMID:
30484592
24.

High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction.

El Sabbagh A, Prasad M, Zack CJ, Widmer RJ, Karon BS, Lerman A, Jaffe AS.

J Invasive Cardiol. 2018 Nov;30(11):406-410.

25.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

26.

Evaluation of the Siemens ADVIA Centaur high-sensitivity cardiac troponin I assay in serum.

Kavsak PA, Worster A, Hill SA, Jaffe AS.

Clin Chim Acta. 2018 Dec;487:216-221. doi: 10.1016/j.cca.2018.10.012. Epub 2018 Oct 6.

PMID:
30296440
27.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2019 Apr 24;57(5):633-640. doi: 10.1515/cclm-2018-0905.

28.

Use of High-Sensitivity Cardiac Troponin in Patients With Chronic Comorbidities: Moving From Theory to Practice.

Jaffe AS, Jaffe HA.

J Am Coll Cardiol. 2018 Sep 4;72(10):1138-1140. doi: 10.1016/j.jacc.2018.06.052. No abstract available.

PMID:
30165985
29.

Fourth universal definition of myocardial infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group .

Eur Heart J. 2019 Jan 14;40(3):237-269. doi: 10.1093/eurheartj/ehy462. No abstract available.

PMID:
30165617
30.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004. Epub 2018 Aug 25. Review. No abstract available.

PMID:
30154043
31.

Fourth Universal Definition of Myocardial Infarction (2018).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.

J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25. No abstract available.

PMID:
30153967
32.

Diagnostic concordance between NT-proBNP and BNP for suspected heart failure.

Farnsworth CW, Bailey AL, Jaffe AS, Scott MG.

Clin Biochem. 2018 Sep;59:50-55. doi: 10.1016/j.clinbiochem.2018.07.002. Epub 2018 Jul 6.

PMID:
30111510
33.

1-h High-Sensitivity Troponin Rule-Out and Rule-In Approach: Strengths and Potential Weaknesses.

Alpert JS, Jaffe AS.

J Am Coll Cardiol. 2018 Aug 7;72(6):633-635. doi: 10.1016/j.jacc.2018.05.041. No abstract available. Erratum in: J Am Coll Cardiol. 2018 Sep 18;72(12):1436.

34.

Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.

Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, Yu PC, Jaffe AS, Barac S, Bock L, Badertscher P, du Fay de Lavallaz J, Marbot S, Sazgary L, Bolliger D, Rentsch K, Twerenbold R, Hammerer-Lercher A, Melo ES, Calderaro D, Duarte AJ, de Luccia N, Caramelli B, Mueller C; TropoVasc and BASEL-PMI Investigators.

Am Heart J. 2018 Sep;203:67-73. doi: 10.1016/j.ahj.2018.06.012. Epub 2018 Jul 5.

PMID:
30041065
35.

Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department.

Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA.

Clin Biochem. 2018 Sep;60:11-16. doi: 10.1016/j.clinbiochem.2018.07.004. Epub 2018 Jul 21.

PMID:
30036510
36.

Possible mechanisms behind cardiac troponin elevations.

Hammarsten O, Mair J, Möckel M, Lindahl B, Jaffe AS.

Biomarkers. 2018 Dec;23(8):725-734. doi: 10.1080/1354750X.2018.1490969. Epub 2018 Aug 23. Review.

PMID:
29976112
37.

Plasma Ceramides.

Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.

PMID:
29903731
38.

Analytical performance of an immunoassay to measure proenkephalin.

Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwaßer A, Jaffe AS.

Clin Biochem. 2018 Aug;58:72-77. doi: 10.1016/j.clinbiochem.2018.05.010. Epub 2018 May 18.

PMID:
29782819
39.

Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study.

Than MP, Aldous SJ, Troughton RW, Pemberton CJ, Richards AM, Frampton CMA, Florkowski CM, George PM, Bailey S, Young JM, Cullen L, Greenslade JH, Parsonage WA, Everett BM, Peacock WF, Jaffe AS, Pickering JW.

Clin Chem. 2018 Jul;64(7):1044-1053. doi: 10.1373/clinchem.2017.285700. Epub 2018 May 14.

40.

Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?

Hickson LJ, Balls-Berry JE, Jaffe AS, Rule AD.

J Am Soc Nephrol. 2018 Jun;29(6):1781. doi: 10.1681/ASN.2017121249. Epub 2018 Apr 20. No abstract available.

41.

Science Moves Slowly.

Jaffe AS, Apple FS.

J Am Coll Cardiol. 2018 Apr 10;71(14):1550-1552. doi: 10.1016/j.jacc.2018.01.068. No abstract available.

42.

Clarifying the Proper Definitions for Type 2 Myocardial Infarction.

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, White HD.

J Am Coll Cardiol. 2018 Mar 20;71(11):1291. doi: 10.1016/j.jacc.2017.12.063. No abstract available.

43.

The prognostic impact of periprocedural myocardial infarction and injury.

Thygesen K, Jaffe AS.

Eur Heart J. 2018 Apr 1;39(13):1110-1112. doi: 10.1093/eurheartj/ehy089. No abstract available.

PMID:
29529182
44.

High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgery.

Duma A, Wagner C, Titz M, Maleczek M, Hüpfl M, Weihs VB, Samaha E, Herkner H, Szekeres T, Mittlboeck M, Scott MG, Jaffe AS, Nagele P.

Br J Anaesth. 2018 Feb;120(2):291-298. doi: 10.1016/j.bja.2017.09.001. Epub 2017 Dec 5.

46.

Meta-Analyses and Interpretation of Troponin Values in Heart Failure.

Jaffe AS, Miller WL.

JACC Heart Fail. 2018 Mar;6(3):198-200. doi: 10.1016/j.jchf.2017.12.001. Epub 2018 Jan 10. No abstract available.

47.

Comparing analytical outliers and the percent of emergency department patients with results above the 99th percentile upper reference limit for 2 conventional and one high sensitivity troponin assay.

Karon BS, Wockenfus AM, Hartung KJ, Scott RJ, Carter SD, Jaffe AS.

Clin Biochem. 2018 Mar;53:104-109. doi: 10.1016/j.clinbiochem.2018.01.001. Epub 2018 Jan 2.

PMID:
29305092
48.

Variability Between Reagent Lots for High-Sensitivity Cardiac Troponin I May Affect Performance of Early Rule Out Strategies.

Kavsak PA, Worster A, Oliver R, Clark L, Parry D, Randell E, Sarfaraz MO, Hill S, Jaffe AS.

Can J Cardiol. 2018 Feb;34(2):209.e5-209.e6. doi: 10.1016/j.cjca.2017.11.010. Epub 2017 Nov 22. No abstract available.

PMID:
29287942
49.

How is cardiac troponin released from injured myocardium?

Mair J, Lindahl B, Hammarsten O, Müller C, Giannitsis E, Huber K, Möckel M, Plebani M, Thygesen K, Jaffe AS.

Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):553-560. doi: 10.1177/2048872617748553. Epub 2017 Dec 27. Review.

PMID:
29278915
50.

Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter.

Lobo R, Jaffe AS, Cahill C, Blake O, Abbas S, Meany TB, Hennessy T, Kiernan TJ.

Am J Cardiol. 2018 Jan 15;121(2):188-192. doi: 10.1016/j.amjcard.2017.10.009. Epub 2017 Oct 19.

PMID:
29221605

Supplemental Content

Loading ...
Support Center